NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Best Buy was downgraded at Goldman Sachs to neutral from buy. Twelve-month price target is $28. New challenges are emerging, Goldman said.
Forest Laboratories (FRX) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $85. Company is in the early stages of a rejuvenation, Credit Suisse said.
Must Read: Analysts' Actions: ADI HPQ MU RL VMW
Rocket Fuel (FUEL) was downgraded at BMO Capital to market perform from outperform. Valuation call, based on a $50 price target, BMO Capital said.
Foster Wheeler (FWLT) was downgraded at UBS to neutral from buy. In the wake of the company's provisional agreement to be combined with AME, the rating reflects more balanced risk profile and limited upside, UBS said. Twelve-month price target is $31.
Nu Skin (NUS) was downgraded at Bank of America/Merrill Lynch to neutral from buy. Twelve-month price target is $94. China investigation will likely hurt sales, BofA/Merrill said.
People's United (PBCT) was downgraded at J.P. Morgan to neutral from overweight. Twelve-month price target is $16. Company guided toward lower earnings, J.P. Morgan said.
Twitter (TWTR - Get Report) was initiated with buy rating at Stifel Nicolaus. Twelve-month price target is $75. Strategic value, business model flexibility and earnings momentum will help move the stock higher, Stifel Nicolaus said.